Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
John P. Butler Insider Profile
11 Followers
John P. Butler, CEO & President, Director at Akebia Therapeutics, holds 2.92M shares in Akebia Therapeutics (Ticker: AKBA), holds 0.00 shares in Zynerba Pharmaceuticals (Ticker: ZYNE), holds 10.00K shares in Keryx Biopharma (Ticker: KERX).
John P. Butler Akebia Therapeutics (AKBA)CEO & President, Director
Akebia Therapeutics (AKBA)
CEO & President, Director
Ranked #74,958 out of 100,516 Corporate Insiders
Profitable Transactions
5 out of 14 Profitable Transactions
Average Return
-8.80%
Average return per transaction
Time Frame
Compare to
Insider Roles
CEO & President, Director
Roles that John P. Butler holds in companies
Most Profitable Insider Trade
Stock:
Zynerba Pharmaceuticals
(ZYNE)
(ZYNE)
Rating:Informative Buy
Date:Aug 22, 2018 - Aug 22, 2019
Return:+80.90%
The most profitable trade made by John P. Butler
John P. Butler's Trading History
Akebia Therapeutics
Feb 04, 2025
CEO & President, Director
Uninformative Buy
―
$5.26M
Keryx Biopharma
Jun 20, 2017
―
Uninformative Buy
―
$33.60K
Zynerba Pharmaceuticals
Oct 11, 2023
―
Uninformative Sell
―
$0.00
Relypsa Inc
Jun 23, 2016
―
Uninformative Buy
―
$123.55K
List of latest transactions for each holding click on a transaction to see John P. Butler's performance on stock
You May Also Like
John P. Butler insider profile FAQ
What is the percentage of profitable transactions made by John P. Butler?
The percentage of profitable transactions made by John P. Butler is 36%.
What is the average return per transaction made by John P. Butler?
The average return per transaction made by John P. Butler is -8.80%.
What stocks does John P. Butler hold?
John P. Butler holds: AKBA, KERX, ZYNE, RLYP stocks.
What was John P. Butler’s latest transaction?
John P. Butler latest transaction was an Uninformative Buy of ―.
What was John P. Butler's most profitable transaction?
John P. Butler’s most profitable transaction was an Informative Buy of ZYNE stock on August 22, 2018. The return on the trade was 80.90%.
What is John P. Butler's role in Akebia Therapeutics?
John P. Butler's role in Akebia Therapeutics is CEO & President, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.